Stockreport

Immix Biopharma to Host Conference Call for Investors, Analysts and Members of the Media

Immix Biopharma, Inc.  (IMMX) 
PDF - Company management will provide an update on positive new developments regarding CAR-T NXC-201 in relapsed/refractory AL Amyloidosis. Following management’s formal rem [Read more]